2017-03-02,Spark Therapeutics To Participate In Multiple Conferences In March
2017-03-01,Spark Therapeutics And Pfizer Announce That SPK-9001, An Investigational Hemophilia B Medicine, Has Been Granted Access To The PRIority MEdicines (PRIME) Program By The European Medicines Agency
2017-02-22,Spark Therapeutics Reports 2016 Financial Results And Business Highlights
2017-02-21,We May Be Back to Maximum Overbought by Thursday
2017-02-15,Spark Therapeutics To Host Conference Call On Wednesday, Feb. 22 At 8:30 A.m. To Discuss 2016 Results
2017-02-03,Spark Therapeutics Reaches Analyst Target Price
2017-01-26,Spark Therapeutics To Participate In Multiple February Conferences
2017-01-09,Spark Therapeutics Announces U.S. Orphan Drug Designation Amendment And Study Updates For Lead Investigational Gene Therapy
2017-01-04,Spark Therapeutics Announces $15 Million Milestone Payment From Pfizer For Progress In Hemophilia B Gene Therapy Program
2017-01-03, Spark Therapeutics To Participate In J.P. Morgan Healthcare Conference
2016-12-05,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
2016-12-05,Spark Therapeutics Adds Chief Operating Officer To Management Team
2016-12-05,Spark Therapeutics Enters Into Licensing Agreement With Selecta Biosciences
2016-12-03,Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions
2016-12-03,Spark Therapeutics And Pfizer Present Updated Preliminary Data From Hemophilia B Phase 1/2 Trial Suggesting Consistent And Sustained Levels Of Factor IX Activity At Annual ASH Meeting
2016-11-30,Spark Therapeutics Announces Multiple Presentations On Updated Hemophilia B Phase 1/2 Data At American Society Of Hematology Annual Meeting
2016-11-03,The Great 'ASH16' Abstract Drop Mostly Causes Drug Stocks to Do Same
2016-11-03,Spark Therapeutics And Pfizer Announce Updated Data From Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels Of Factor IX Activity
2016-11-03,Spark Therapeutics Reports Third Quarter 2016 Financial Results And Recent Business Highlights
2016-10-31,Spark Therapeutics To Participate In Multiple Upcoming Conferences
2016-10-27,Spark Therapeutics To Host Conference Call On Thursday, Nov. 3 At 8:30 A.m. To Discuss Third Quarter 2016 Results
2016-10-20,Spark Therapeutics Announces Collaboration With Leading Gene Therapy Center At University Of Massachusetts Medical School
2016-10-14,Data Presented Today At The American Academy Of Ophthalmology 2016 Annual Meeting Reinforce Efficacy And Durability Of Voretigene Neparvovec In RPE65-Mediated Inherited Retinal Disease
2016-10-13,Spark Therapeutics Launches Initiative To Improve Access To Genetic Testing For Inherited Retinal Diseases
2016-10-10, Spark Therapeutics To Participate In AAO Annual Meeting
2016-09-21,Spark Therapeutics To Participate In Multiple Upcoming Conferences
2016-09-09,Jim Cramer's Top Takeaways: Spark Therapeutics, General Mills, Kellogg, ConAgra, Campbell
2016-09-08,Jim Cramer's 'Mad Money' Recap: This Market Has a One-Track Mind
2016-08-31,Spark Therapeutics To Participate In Multiple September Conferences
2016-08-10,Spark Therapeutics Reports Second Quarter 2016 Financial Results And Recent Business Highlights
2016-08-10,Spark Therapeutics Announces New Positive Data From Continuation Of Phase 3 Trial Of Voretigene Neparvovec
2016-08-02,Spark Therapeutics, Inc. To Host Conference Call On August 10th At 8:30a.m. To Discuss Second Quarter 2016 Results
2016-07-25,Spark Therapeutics And Pfizer Announce Updated Data From First Cohort In Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels Of Factor IX Activity
2016-07-21,13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys
2016-07-21,Spark Therapeutics And Pfizer Announce Receipt Of FDA Breakthrough Therapy Designation For SPK-9001 For The Treatment Of Hemophilia B
2016-07-12,Strong On High Relative Volume: Spark Therapeutics (ONCE)
2016-07-08,Spark Therapeutics Announces Participation In Conferences In July
2016-07-01,Spark Therapeutics Announces Publication Of Positive Follow-Up Data From Phase 1 Trial Of Voretigene Neparvovec In The Lancet
2016-06-30,'Mad Money' Lightning Round: You Should Own General Electric
2016-06-29,Jim Cramer's 'Mad Money' Recap: What a Relief! This Rally Has Legs
2016-06-20,Spark Therapeutics Announces Closing Of Public Offering
2016-06-16,Spark Therapeutics (ONCE) Stock: Weak On High Volume Today
2016-06-15,Spark Therapeutics (ONCE) Trading With Heavy Volume Before Market Open
2016-06-14,Spark Therapeutics Announces Pricing Of Public Offering
2016-06-13,Spark Therapeutics Announces Launch Of Public Offering
2016-06-13,Spark Therapeutics Announces Updated Data From First Cohort In Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels Of Factor IX Activity
2016-06-09,Spark Therapeutics, Inc. To Host Conference Call On Monday June 13th At 8:30 A.m. To Discuss SPK-9001 Phase 1/2 Data For The Treatment Of Hemophilia B Presented At EHA
2016-06-06,Spark Therapeutics Announces Participation And Attendance For Conferences In June
2016-05-24,Spark Therapeutics (ONCE) Highlighted As Today's Perilous Reversal Stock
2016-05-19,Strong On High Relative Volume: Spark Therapeutics (ONCE)
2016-05-19,Spark Therapeutics And Pfizer Announce Data From Initial Subjects In Hemophilia B Trial Demonstrating Consistent Therapeutic Levels Of Factor IX Expression
2016-05-04,Spark Therapeutics Reports First Quarter 2016 Financial Results And Recent Business Highlights
2016-05-03,Spark Therapeutics Announces Multiple Presentations At Upcoming Investor Meetings
2016-04-28,Spark Therapeutics Announces Multiple Presentations At Upcoming Scientific Meetings
2016-04-27,Spark Therapeutics, Inc. To Host Conference Call On May 4th At 8:30a.m. To Discuss First Quarter 2016 Results
2016-03-11,Analysts' Actions -- Blackstone, Chevron, Hertz, Kohl's and More
2016-03-10,Ratings Changes Today
2016-03-09,Spark Therapeutics Reports 2015 Financial Results And Business Highlights
2016-03-07,Spark Therapeutics Announces Acquisition Of Genable Technologies
2016-03-02,Spark Therapeutics Announces Cowen Healthcare Conference Participation
2016-03-02,Spark Therapeutics, Inc. To Host Conference Call On March 9th At 8:30 A.m. To Discuss 2015 Results
2016-02-29,Spark Therapeutics Announces Launch Of ASharedVision, A New Online Resource To Unite And Inform Those Affected By Inherited Retinal Diseases
2016-02-11,Commit To Buy Spark Therapeutics At $20, Earn 29.3% Annualized Using Options
2016-02-08,Relative Strength Alert For Spark Therapeutics
2016-02-01,Emerald Investment Conference Shadows Groundhog Day - Investment Professionals Gathering In Philadelphia On February 3rd
2016-01-21,WHAT'S AHEAD FOR 2016: Investment Trends And Themes To Be Highlighted At The Emerald Groundhog Day Investment Forum
2016-01-11,Spark Unveils Vision Of Having 10 Clinical-Stage Gene Therapy Programs By 2018, Including One Commercial And Two In Pivotal Trials
2016-01-06,Spark Therapeutics Announces Addition Of Lota Zoth To Its Board Of Directors
2016-01-05,Spark Therapeutics Announces J.P. Morgan Healthcare Conference Participation
2016-01-01,Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
2015-12-15,Spark Therapeutics Announces Pricing Of Public Offering
2015-12-14,Spark Therapeutics Announces Launch Of Public Offering
2015-12-14,Spark Therapeutics Announces Addition To NASDAQ Biotechnology Index
2015-12-09,Spark Therapeutics Announces $15 Million Milestone Payment From Pfizer For Progress In Hemophilia B Gene Therapy Program
2015-11-30,Spark Therapeutics Announces December Conference Participation
2015-11-25,Spark Therapeutics Announces Filing Of Registration Statement For Proposed Public Offering
2015-11-14,Spark Therapeutics Announces Presentation Of Additional Phase 3 Data On SPK-RPE65 At The American Academy Of Ophthalmology 2015 Annual Meeting
2015-11-11,Spark Therapeutics Announces SPK-TPP1, Its First Program Targeting Neurodegenerative Disease
2015-11-04,Spark Therapeutics Reports Third Quarter 2015 Financial Results And Recent Business Highlights
2015-10-28,Spark Therapeutics, Inc. To Host Conference Call On November 4th At 8:30a.m. To Discuss Third Quarter 2015 Results
2015-10-23,Spark Therapeutics To Participate In Four Conferences In October And November
2015-10-14,5 Stocks Insiders Love Right Now
2015-10-10,Spark Therapeutics Announces Presentation Of Additional Phase 3 And Durability Data On SPK-RPE65 At The Retina Society 48th Annual Scientific Meeting
2015-10-05,Apple Sits Out Tech Rally; S&P 500 Enjoys Record 2015 Winning Streak
2015-10-05,Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
2015-10-05,Spark Therapeutics Announces Positive Top-line Results From Pivotal Phase 3 Trial Of SPK-RPE65 For Genetic Blinding Conditions
2015-09-29,'Mad Money' Lightning Round: Take PPG Over Sherwin-Williams
2015-09-28,Jim Cramer's 'Mad Money' Recap: 5 Groups You Once Loved but Now Hate
2015-09-25,Biotech Stock Mailbag: Rebounding From Hillary's Drug Tweet; Global Blood Weighs on Bluebird
2015-09-18,5 Stocks Ready for Breakouts
2015-09-10,Spark Tries to Quell Investor Fears About Gene Therapy Test
2015-09-09,Spark Therapeutics Announces Database Lock For SPK-RPE65 Phase 3 Clinical Trial And Expected Release Of Top-Line Data In October
2015-09-03,Biotech Stock Mailbag: Sarepta, Biomarin, Spark, Raptor
2015-09-01,The Numbers Behind Biotech's Horrible, No Good, Awful August
2015-08-19,Biotech Stocks Get Burned This Summer, but Fall Might Bring Relief
2015-08-05,Spark Therapeutics Reports Second Quarter 2015 Results
2015-07-29,Spark Therapeutics, Inc. To Host Conference Call On August 5th At 8:30a.m. To Discuss Second Quarter 2015 Results
2015-07-23,Jim Cramer: Spark Therapeutics (ONCE) Is Capable of Doing Amazing Things
2015-07-23,Jim Cramer's Top Takeaways: Live Nation, Spark Therapeutics, Ambarella
2015-07-22,Jim Cramer's 'Mad Money' Recap: Road to China Is Lined With Bears and Bulls
2015-06-26,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2015-06-18,Spark Therapeutics To Present With Pfizer Inc. Preclinical Data On Their Lead SPK-FIX Product Candidate For Hemophilia B At The 2015 International Society Of Thrombosis And Haemostasis Congress In June
2015-06-18,'Mad Money' Lightning Round: Buy, Buy, Buy Celgene; I'm a Believer
2015-06-17,Jim Cramer's 'Mad Money' Recap: Thanks for Nothing, Janet Yellen
2015-06-17,Spark Therapeutics To Participate In Two International Conferences In London In June
2015-06-13,Bluebird Sickle Cell Gene Therapy Results Keep Getting Better
2015-05-21,Bluebird Bio First Look at Gene Therapy for Sickle Cell Disease
2015-05-06,Spark Therapeutics Reports First Quarter 2015 Results
2015-05-04,Spark Therapeutics Drops After Rival Blindness Therapy Effectiveness Declines
2015-05-01,Spark Therapeutics To Have Multiple Presentations At 2015 ARVO Meeting
2015-04-30,Spark Therapeutics, Inc. To Host Conference Call On May 6th At 8:30a.m. To Discuss First Quarter 2015 Results
2015-04-28,Spark Therapeutics And Clearside Biomedical Announce Exclusive Option To License Technology For Potentially Differentiated Delivery Of Gene Therapy To The Eye
2015-04-26,Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial
2015-04-17,IPO Market 'Has Been a Lonely Place' but Pace Is Picking Up
2015-04-16,The Top 5 Best IPO Performers in the Last Year
2015-04-06,Biotech Stocks Still Feeling Healthy Despite Bubble Talk
2015-03-25,Celladon Heart-Failure Study Looms Large as Next Big Test for Gene Therapy
2015-03-18,Spark Therapeutics Reports Full Year 2014 Financial Results
2015-03-17,'Mad Money' Lightning Round: I LIke H&R Block, RR Donnelley
2015-03-16,Jim Cramer's 'Mad Money' Recap: This Is One Stupid Market
2015-02-26,Spark Therapeutics To Participate In The 35th Annual Cowen And Company Health Care Conference
2015-02-04,Spark Therapeutics Announces Closing Of Its Initial Public Offering
2015-01-30,IPO Roundup: Shake Shack Shares More Than Double Out of Gate
2015-01-30,Spark Therapeutics Announces Pricing Of Its Initial Public Offering
,
2017-03-02,Spark Therapeutics To Participate In Multiple Conferences In March
2017-03-01,Spark Therapeutics And Pfizer Announce That SPK-9001, An Investigational Hemophilia B Medicine, Has Been Granted Access To The PRIority MEdicines (PRIME) Program By The European Medicines Agency
2017-02-22,Spark Therapeutics Reports 2016 Financial Results And Business Highlights
2017-02-21,We May Be Back to Maximum Overbought by Thursday
2017-02-15,Spark Therapeutics To Host Conference Call On Wednesday, Feb. 22 At 8:30 A.m. To Discuss 2016 Results
2017-02-03,Spark Therapeutics Reaches Analyst Target Price
2017-01-26,Spark Therapeutics To Participate In Multiple February Conferences
2017-01-09,Spark Therapeutics Announces U.S. Orphan Drug Designation Amendment And Study Updates For Lead Investigational Gene Therapy
2017-01-04,Spark Therapeutics Announces $15 Million Milestone Payment From Pfizer For Progress In Hemophilia B Gene Therapy Program
2017-01-03, Spark Therapeutics To Participate In J.P. Morgan Healthcare Conference
2016-12-05,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
2016-12-05,Spark Therapeutics Adds Chief Operating Officer To Management Team
2016-12-05,Spark Therapeutics Enters Into Licensing Agreement With Selecta Biosciences
2016-12-03,Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions
2016-12-03,Spark Therapeutics And Pfizer Present Updated Preliminary Data From Hemophilia B Phase 1/2 Trial Suggesting Consistent And Sustained Levels Of Factor IX Activity At Annual ASH Meeting
2016-11-30,Spark Therapeutics Announces Multiple Presentations On Updated Hemophilia B Phase 1/2 Data At American Society Of Hematology Annual Meeting
2016-11-03,The Great 'ASH16' Abstract Drop Mostly Causes Drug Stocks to Do Same
2016-11-03,Spark Therapeutics And Pfizer Announce Updated Data From Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels Of Factor IX Activity
2016-11-03,Spark Therapeutics Reports Third Quarter 2016 Financial Results And Recent Business Highlights
2016-10-31,Spark Therapeutics To Participate In Multiple Upcoming Conferences
2016-10-27,Spark Therapeutics To Host Conference Call On Thursday, Nov. 3 At 8:30 A.m. To Discuss Third Quarter 2016 Results
2016-10-20,Spark Therapeutics Announces Collaboration With Leading Gene Therapy Center At University Of Massachusetts Medical School
2016-10-14,Data Presented Today At The American Academy Of Ophthalmology 2016 Annual Meeting Reinforce Efficacy And Durability Of Voretigene Neparvovec In RPE65-Mediated Inherited Retinal Disease
2016-10-13,Spark Therapeutics Launches Initiative To Improve Access To Genetic Testing For Inherited Retinal Diseases
2016-10-10, Spark Therapeutics To Participate In AAO Annual Meeting
2016-09-21,Spark Therapeutics To Participate In Multiple Upcoming Conferences
2016-09-09,Jim Cramer's Top Takeaways: Spark Therapeutics, General Mills, Kellogg, ConAgra, Campbell
2016-09-08,Jim Cramer's 'Mad Money' Recap: This Market Has a One-Track Mind
2016-08-31,Spark Therapeutics To Participate In Multiple September Conferences
2016-08-10,Spark Therapeutics Reports Second Quarter 2016 Financial Results And Recent Business Highlights
2016-08-10,Spark Therapeutics Announces New Positive Data From Continuation Of Phase 3 Trial Of Voretigene Neparvovec
2016-08-02,Spark Therapeutics, Inc. To Host Conference Call On August 10th At 8:30a.m. To Discuss Second Quarter 2016 Results
2016-07-25,Spark Therapeutics And Pfizer Announce Updated Data From First Cohort In Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels Of Factor IX Activity
2016-07-21,13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys
2016-07-21,Spark Therapeutics And Pfizer Announce Receipt Of FDA Breakthrough Therapy Designation For SPK-9001 For The Treatment Of Hemophilia B
2016-07-12,Strong On High Relative Volume: Spark Therapeutics (ONCE)
2016-07-08,Spark Therapeutics Announces Participation In Conferences In July
2016-07-01,Spark Therapeutics Announces Publication Of Positive Follow-Up Data From Phase 1 Trial Of Voretigene Neparvovec In The Lancet
2016-06-30,'Mad Money' Lightning Round: You Should Own General Electric
2016-06-29,Jim Cramer's 'Mad Money' Recap: What a Relief! This Rally Has Legs
2016-06-20,Spark Therapeutics Announces Closing Of Public Offering
2016-06-16,Spark Therapeutics (ONCE) Stock: Weak On High Volume Today
2016-06-15,Spark Therapeutics (ONCE) Trading With Heavy Volume Before Market Open
2016-06-14,Spark Therapeutics Announces Pricing Of Public Offering
2016-06-13,Spark Therapeutics Announces Launch Of Public Offering
2016-06-13,Spark Therapeutics Announces Updated Data From First Cohort In Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels Of Factor IX Activity
2016-06-09,Spark Therapeutics, Inc. To Host Conference Call On Monday June 13th At 8:30 A.m. To Discuss SPK-9001 Phase 1/2 Data For The Treatment Of Hemophilia B Presented At EHA
2016-06-06,Spark Therapeutics Announces Participation And Attendance For Conferences In June
2016-05-24,Spark Therapeutics (ONCE) Highlighted As Today's Perilous Reversal Stock
2016-05-19,Strong On High Relative Volume: Spark Therapeutics (ONCE)
2016-05-19,Spark Therapeutics And Pfizer Announce Data From Initial Subjects In Hemophilia B Trial Demonstrating Consistent Therapeutic Levels Of Factor IX Expression
2016-05-04,Spark Therapeutics Reports First Quarter 2016 Financial Results And Recent Business Highlights
2016-05-03,Spark Therapeutics Announces Multiple Presentations At Upcoming Investor Meetings
2016-04-28,Spark Therapeutics Announces Multiple Presentations At Upcoming Scientific Meetings
2016-04-27,Spark Therapeutics, Inc. To Host Conference Call On May 4th At 8:30a.m. To Discuss First Quarter 2016 Results
2016-03-11,Analysts' Actions -- Blackstone, Chevron, Hertz, Kohl's and More
2016-03-10,Ratings Changes Today
2016-03-09,Spark Therapeutics Reports 2015 Financial Results And Business Highlights
2016-03-07,Spark Therapeutics Announces Acquisition Of Genable Technologies
2016-03-02,Spark Therapeutics Announces Cowen Healthcare Conference Participation
2016-03-02,Spark Therapeutics, Inc. To Host Conference Call On March 9th At 8:30 A.m. To Discuss 2015 Results
2016-02-29,Spark Therapeutics Announces Launch Of ASharedVision, A New Online Resource To Unite And Inform Those Affected By Inherited Retinal Diseases
2016-02-11,Commit To Buy Spark Therapeutics At $20, Earn 29.3% Annualized Using Options
2016-02-08,Relative Strength Alert For Spark Therapeutics
2016-02-01,Emerald Investment Conference Shadows Groundhog Day - Investment Professionals Gathering In Philadelphia On February 3rd
2016-01-21,WHAT'S AHEAD FOR 2016: Investment Trends And Themes To Be Highlighted At The Emerald Groundhog Day Investment Forum
2016-01-11,Spark Unveils Vision Of Having 10 Clinical-Stage Gene Therapy Programs By 2018, Including One Commercial And Two In Pivotal Trials
2016-01-06,Spark Therapeutics Announces Addition Of Lota Zoth To Its Board Of Directors
2016-01-05,Spark Therapeutics Announces J.P. Morgan Healthcare Conference Participation
2016-01-01,Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
2015-12-15,Spark Therapeutics Announces Pricing Of Public Offering
2015-12-14,Spark Therapeutics Announces Launch Of Public Offering
2015-12-14,Spark Therapeutics Announces Addition To NASDAQ Biotechnology Index
2015-12-09,Spark Therapeutics Announces $15 Million Milestone Payment From Pfizer For Progress In Hemophilia B Gene Therapy Program
2015-11-30,Spark Therapeutics Announces December Conference Participation
2015-11-25,Spark Therapeutics Announces Filing Of Registration Statement For Proposed Public Offering
2015-11-14,Spark Therapeutics Announces Presentation Of Additional Phase 3 Data On SPK-RPE65 At The American Academy Of Ophthalmology 2015 Annual Meeting
2015-11-11,Spark Therapeutics Announces SPK-TPP1, Its First Program Targeting Neurodegenerative Disease
2015-11-04,Spark Therapeutics Reports Third Quarter 2015 Financial Results And Recent Business Highlights
2015-10-28,Spark Therapeutics, Inc. To Host Conference Call On November 4th At 8:30a.m. To Discuss Third Quarter 2015 Results
2015-10-23,Spark Therapeutics To Participate In Four Conferences In October And November
2015-10-14,5 Stocks Insiders Love Right Now
2015-10-10,Spark Therapeutics Announces Presentation Of Additional Phase 3 And Durability Data On SPK-RPE65 At The Retina Society 48th Annual Scientific Meeting
2015-10-05,Apple Sits Out Tech Rally; S&P 500 Enjoys Record 2015 Winning Streak
2015-10-05,Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
2015-10-05,Spark Therapeutics Announces Positive Top-line Results From Pivotal Phase 3 Trial Of SPK-RPE65 For Genetic Blinding Conditions
2015-09-29,'Mad Money' Lightning Round: Take PPG Over Sherwin-Williams
2015-09-28,Jim Cramer's 'Mad Money' Recap: 5 Groups You Once Loved but Now Hate
2015-09-25,Biotech Stock Mailbag: Rebounding From Hillary's Drug Tweet; Global Blood Weighs on Bluebird
2015-09-18,5 Stocks Ready for Breakouts
2015-09-10,Spark Tries to Quell Investor Fears About Gene Therapy Test
2015-09-09,Spark Therapeutics Announces Database Lock For SPK-RPE65 Phase 3 Clinical Trial And Expected Release Of Top-Line Data In October
2015-09-03,Biotech Stock Mailbag: Sarepta, Biomarin, Spark, Raptor
2015-09-01,The Numbers Behind Biotech's Horrible, No Good, Awful August
2015-08-19,Biotech Stocks Get Burned This Summer, but Fall Might Bring Relief
2015-08-05,Spark Therapeutics Reports Second Quarter 2015 Results
2015-07-29,Spark Therapeutics, Inc. To Host Conference Call On August 5th At 8:30a.m. To Discuss Second Quarter 2015 Results
2015-07-23,Jim Cramer: Spark Therapeutics (ONCE) Is Capable of Doing Amazing Things
2015-07-23,Jim Cramer's Top Takeaways: Live Nation, Spark Therapeutics, Ambarella
2015-07-22,Jim Cramer's 'Mad Money' Recap: Road to China Is Lined With Bears and Bulls
2015-06-26,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2015-06-18,Spark Therapeutics To Present With Pfizer Inc. Preclinical Data On Their Lead SPK-FIX Product Candidate For Hemophilia B At The 2015 International Society Of Thrombosis And Haemostasis Congress In June
2015-06-18,'Mad Money' Lightning Round: Buy, Buy, Buy Celgene; I'm a Believer
2015-06-17,Jim Cramer's 'Mad Money' Recap: Thanks for Nothing, Janet Yellen
2015-06-17,Spark Therapeutics To Participate In Two International Conferences In London In June
2015-06-13,Bluebird Sickle Cell Gene Therapy Results Keep Getting Better
2015-05-21,Bluebird Bio First Look at Gene Therapy for Sickle Cell Disease
2015-05-06,Spark Therapeutics Reports First Quarter 2015 Results
2015-05-04,Spark Therapeutics Drops After Rival Blindness Therapy Effectiveness Declines
2015-05-01,Spark Therapeutics To Have Multiple Presentations At 2015 ARVO Meeting
2015-04-30,Spark Therapeutics, Inc. To Host Conference Call On May 6th At 8:30a.m. To Discuss First Quarter 2015 Results
2015-04-28,Spark Therapeutics And Clearside Biomedical Announce Exclusive Option To License Technology For Potentially Differentiated Delivery Of Gene Therapy To The Eye
2015-04-26,Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial
2015-04-17,IPO Market 'Has Been a Lonely Place' but Pace Is Picking Up
2015-04-16,The Top 5 Best IPO Performers in the Last Year
2015-04-06,Biotech Stocks Still Feeling Healthy Despite Bubble Talk
2015-03-25,Celladon Heart-Failure Study Looms Large as Next Big Test for Gene Therapy
2015-03-18,Spark Therapeutics Reports Full Year 2014 Financial Results
2015-03-17,'Mad Money' Lightning Round: I LIke H&R Block, RR Donnelley
2015-03-16,Jim Cramer's 'Mad Money' Recap: This Is One Stupid Market
2015-02-26,Spark Therapeutics To Participate In The 35th Annual Cowen And Company Health Care Conference
2015-02-04,Spark Therapeutics Announces Closing Of Its Initial Public Offering
2015-01-30,IPO Roundup: Shake Shack Shares More Than Double Out of Gate
2015-01-30,Spark Therapeutics Announces Pricing Of Its Initial Public Offering
,
